COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine

Cheng Lay Teh¹, Yaw Kiet Cheong², Wan Rosmaiza Wan Musa³, Sharifah Aishah Wan Mohd Akbar², Noraini Mat Husin⁴, Suk Chyn Gun⁵

Affiliations

¹ Department of Medicine, Sarawak General Hospital, Kuching, Sarawak, Malaysia tehchenglay@yahoo.com.
² Department of Medicine, Sarawak General Hospital, Kuching, Sarawak, Malaysia.
³ Department of Medicine, Hospital Putrajaya, Putrajaya, Malaysia.
⁴ Department of Medicine, Hospital Ipoh, Ipoh, Perak, Malaysia.
⁵ Department of Medicine, Hospital Tuanku Ja'afar Seremban, Seremban, Negeri Sembilan, Malaysia.

PMID: 32737111
DOI: 10.1136/annrheumdis-2020-218154

Comment

COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine

Cheng Lay Teh et al. Ann Rheum Dis. 2021 May.

. 2021 May;80(5):e69.

doi: 10.1136/annrheumdis-2020-218154. Epub 2020 Jul 31.

Authors

Cheng Lay Teh¹, Yaw Kiet Cheong², Wan Rosmaiza Wan Musa³, Sharifah Aishah Wan Mohd Akbar², Noraini Mat Husin⁴, Suk Chyn Gun⁵

Affiliations

¹ Department of Medicine, Sarawak General Hospital, Kuching, Sarawak, Malaysia tehchenglay@yahoo.com.
² Department of Medicine, Sarawak General Hospital, Kuching, Sarawak, Malaysia.
³ Department of Medicine, Hospital Putrajaya, Putrajaya, Malaysia.
⁴ Department of Medicine, Hospital Ipoh, Ipoh, Perak, Malaysia.
⁵ Department of Medicine, Hospital Tuanku Ja'afar Seremban, Seremban, Negeri Sembilan, Malaysia.

PMID: 32737111
DOI: 10.1136/annrheumdis-2020-218154

No abstract available

Keywords: epidemiology; hydroxychloroquine; lupus erythematosus, systemic.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment in

Response to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh et al.
Mathian A, Amoura Z. Mathian A, et al. Ann Rheum Dis. 2021 May;80(5):e70. doi: 10.1136/annrheumdis-2020-218173. Epub 2020 Jul 31. Ann Rheum Dis. 2021. PMID: 32737109 No abstract available.

Comment on

Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.
Mathian A, Mahevas M, Rohmer J, Roumier M, Cohen-Aubart F, Amador-Borrero B, Barrelet A, Chauvet C, Chazal T, Delahousse M, Devaux M, Euvrard R, Fadlallah J, Florens N, Haroche J, Hié M, Juillard L, Lhote R, Maillet T, Richard-Colmant G, Palluy JB, Pha M, Perard L, Remy P, Rivière E, Sène D, Sève P, Morélot-Panzini C, Viallard JF, Virot JS, Benameur N, Zahr N, Yssel H, Godeau B, Amoura Z. Mathian A, et al. Ann Rheum Dis. 2020 Jun;79(6):837-839. doi: 10.1136/annrheumdis-2020-217566. Epub 2020 Apr 24. Ann Rheum Dis. 2020. PMID: 32332072 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine

Affiliations

COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine

Authors

Affiliations

Conflict of interest statement

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources